{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:11:33Z","timestamp":1761808293940,"version":"build-2065373602"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gene"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.gene.2019.143947","type":"journal-article","created":{"date-parts":[[2019,6,25]],"date-time":"2019-06-25T12:52:44Z","timestamp":1561467164000},"page":"143947","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["PPARA, PPARD and PPARG gene polymorphisms in patients with unstable angina"],"prefix":"10.1016","volume":"711","author":[{"given":"Agnieszka","family":"Maciejewska-Skrendo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6557-1208","authenticated-orcid":false,"given":"Andrzej","family":"Pawlik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marek","family":"Sawczuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Ra\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrzej","family":"Kusak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krzysztof","family":"Safranow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Violetta","family":"Dziedziejko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.gene.2019.143947_bb0005","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1017\/S0029665111003181","article-title":"Effect of interaction between PPARG, PPARA and ADIPOQ gene variants and dietary fatty acids on plasma lipid profile and adiponectin concentration in a large intervention study","volume":"71","author":"AlSaleh","year":"2012","journal-title":"Proc. Nutr. Soc."},{"issue":"9","key":"10.1016\/j.gene.2019.143947_bb0010","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1161\/01.STR.0000138784.68159.a5","article-title":"Genetic variation in PPARG encoding peroxisome proliferator-activated receptor gamma associated with carotid atherosclerosis","volume":"35","author":"Al-Shali","year":"2004","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.gene.2019.143947_bb0015","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1161\/CIRCRESAHA.117.306458","article-title":"Environmental determinants of cardiovascular disease","volume":"121","author":"Bhatnagar","year":"2017","journal-title":"Circ. Res."},{"issue":"9","key":"10.1016\/j.gene.2019.143947_bb0020","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1089\/dia.2011.0277","article-title":"Ala\/Ala genotype of Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-\u03b32 gene is associated with obesity and insulin resistance in Asian Indians","volume":"14","author":"Bhatt","year":"2012","journal-title":"Diabetes Technol. Ther."},{"issue":"1","key":"10.1016\/j.gene.2019.143947_bb0025","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.pop.2017.10.001","article-title":"Coronary artery disease: diagnosis and management","volume":"45","author":"Cagle","year":"2018","journal-title":"Prim. Care"},{"key":"10.1016\/j.gene.2019.143947_bb0030","doi-asserted-by":"crossref","DOI":"10.1155\/2009\/543746","article-title":"Peroxisome proliferator-activated receptor gamma polymorphisms and coronary heart disease","volume":"2009","author":"Dallongeville","year":"2009","journal-title":"PPAR Res."},{"issue":"3","key":"10.1016\/j.gene.2019.143947_bb0035","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/3099","article-title":"A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity","volume":"20","author":"Deeb","year":"1998","journal-title":"Nat. Genet."},{"issue":"19\u201320","key":"10.1016\/j.gene.2019.143947_bb0040","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s00508-012-0223-0","article-title":"The meta-analysis of the association of PPARG P12A, C161T polymorphism and coronary heart disease","volume":"124","author":"Ding","year":"2012","journal-title":"Wien. Klin. Wochenschr."},{"issue":"9","key":"10.1016\/j.gene.2019.143947_bb0045","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S1471-4914(02)02385-7","article-title":"The role of PPARs in atherosclerosis","volume":"8","author":"Duval","year":"2002","journal-title":"Trends Mol. Med."},{"issue":"1","key":"10.1016\/j.gene.2019.143947_bb0050","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.atherosclerosis.2008.11.009","article-title":"PPARgamma promoter polymorphisms and acute coronary syndrome","volume":"205","author":"Evangelisti","year":"2009","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.gene.2019.143947_bb0055","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1161\/HYPERTENSIONAHA.115.06532","article-title":"Vascular matrix metalloproteinase inhibition, a new mechanism for how peroxisome proliferator-activated receptor-\u03b3 protects target organ damage","volume":"67","author":"Forrester","year":"2016","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.gene.2019.143947_bb0060","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1155\/2010\/501730","article-title":"Homozygosity for the Ala allele of the PPAR\u03b32 Pro12Ala polymorphism is associated with reduced risk of coronary artery disease","volume":"29","author":"Galgani","year":"2010","journal-title":"Dis. Markers"},{"issue":"3","key":"10.1016\/j.gene.2019.143947_bb0065","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.diabres.2012.03.012","article-title":"Association of the PPARG Pro12Ala polymorphism with type 2 diabetes and incident coronary heart disease in a Hong Kong Chinese population","volume":"97","author":"Ho","year":"2012","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"43","key":"10.1016\/j.gene.2019.143947_bb0070","doi-asserted-by":"crossref","first-page":"27988","DOI":"10.1074\/jbc.273.43.27988","article-title":"A carboxyl-terminal extension of the zinc finger domain contributes to the specificity and polarity of peroxisome proliferator activated receptor DNA binding","volume":"273","author":"Hsu","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.gene.2019.143947_bb0075","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1096\/fj.11-188607","article-title":"PPAR\u03b1 and PPAR\u03b3 protect against HIV-1-induced MMP-9 overexpression via caveolae-associated ERK and Akt signaling","volume":"25","author":"Huang","year":"2011","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.gene.2019.143947_bb0080","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0168-8227(03)00161-X","article-title":"The association of Pro12Ala polymorphism in PPARgamma2 with lower carotid artery IMT in Japanese","volume":"62","author":"Iwata","year":"2003","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"4","key":"10.1016\/j.gene.2019.143947_bb0085","doi-asserted-by":"crossref","first-page":"18662","DOI":"10.4238\/2015.December.28.15","article-title":"Association of the PPAR\u03b32 Pro12Ala polymorphism with increased risk of cardiovascular diseases","volume":"14","author":"Li","year":"2015","journal-title":"Genet. Mol. Res."},{"issue":"1","key":"10.1016\/j.gene.2019.143947_bb0090","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1006\/bbrc.2000.2096","article-title":"Inhibitory effect of a proline-to-alanine substitution at codon 12 of peroxisome proliferator-activated receptor-gamma 2 on thiazolidinedione-induced adipogenesis","volume":"268","author":"Masugi","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1\u20132","key":"10.1016\/j.gene.2019.143947_bb0095","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ymgme.2004.08.014","article-title":"Impact of genetic variation of PPARgamma in humans","volume":"83","author":"Meirhaeghe","year":"2004","journal-title":"Mol. Genet. Metab."},{"issue":"4","key":"10.1016\/j.gene.2019.143947_bb0100","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1124\/pr.58.4.5","article-title":"International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors","volume":"58","author":"Michalik","year":"2006","journal-title":"Pharmacol. Rev."},{"issue":"5","key":"10.1016\/j.gene.2019.143947_bb0105","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.plefa.2011.04.016","article-title":"New insights into the role of PPARs","volume":"85","author":"Montagner","year":"2011","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"issue":"1\u20133","key":"10.1016\/j.gene.2019.143947_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2011.09.158","article-title":"Polymorphism of peroxisome proliferator-activated receptor \u03b3 (PPAR\u03b3) Pro12Ala in the Iranian population: relation with insulin resistance and response to treatment with pioglitazone in type 2 diabetes","volume":"671","author":"Namvaran","year":"2011","journal-title":"Eur. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.gene.2019.143947_bb0115","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1161\/01.ATV.0000171993.78135.7e","article-title":"Peroxisome proliferator-activated receptor-gamma2 P12A polymorphism and risk of coronary heart disease in US men and women","volume":"25","author":"Pischon","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"3","key":"10.1016\/j.gene.2019.143947_bb0120","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1253\/circj.71.338","article-title":"No association of Pro12Ala polymorphism of PPAR-gamma gene with coronary artery disease in Korean subjects","volume":"71","author":"Rhee","year":"2007","journal-title":"Circ. J."},{"issue":"5","key":"10.1016\/j.gene.2019.143947_bb0125","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1161\/01.ATV.0000068680.19521.34","article-title":"Alanine for proline substitution in the peroxisome proliferator-activated receptor gamma-2 (PPARG2) gene and the risk of incident myocardial infarction","volume":"23","author":"Ridker","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.gene.2019.143947_bb0130","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis\u2014an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.gene.2019.143947_bb0135","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1093\/ajcn\/86.4.1238","article-title":"Ala12 variant of the peroxisome proliferator-activated receptor-gamma gene (PPARG) is associated with higher polyunsaturated fat in adipose tissue and attenuates the protective effect of polyunsaturated fat intake on the risk of myocardial infarction","volume":"86","author":"Ruiz-Narv\u00e1ez","year":"2007","journal-title":"Am. J. Clin. Nutr."},{"issue":"4","key":"10.1016\/j.gene.2019.143947_bb0140","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1161\/01.ATV.0000064383.88696.24","article-title":"Evidence that peroxisome proliferator-activated receptor delta influences cholesterol metabolism in men","volume":"23","author":"Skogsberg","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"6","key":"10.1016\/j.gene.2019.143947_bb0145","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1365-2796.2003.01236.x","article-title":"West of Scotland Coronary Prevention Study. Peroxisome proliferator activated receptor delta genotype in relation to cardiovascular risk factors and risk of coronary heart disease in hypercholesterolaemic men","volume":"254","author":"Skogsberg","year":"2003","journal-title":"J. Intern. Med."},{"issue":"9","key":"10.1016\/j.gene.2019.143947_bb0150","doi-asserted-by":"crossref","first-page":"4238","DOI":"10.1210\/jc.2003-032120","article-title":"Ala12Ala genotype of the peroxisome proliferator-activated receptor gamma2 protects against atherosclerosis","volume":"89","author":"Temelkova-Kurktschiev","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.gene.2019.143947_bb0155","first-page":"410","article-title":"The role of the Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma in diabetes risk","volume":"10","author":"T\u00f6njes","year":"2007","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"10.1016\/j.gene.2019.143947_bb0160","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1471-2350-10-52","article-title":"PPARgamma Pro12Ala polymorphism and risk of acute coronary syndrome in a prospective study of Danes","volume":"10","author":"Vogel","year":"2009","journal-title":"BMC Med. Genet."},{"issue":"7","key":"10.1016\/j.gene.2019.143947_bb0165","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.tem.2012.05.001","article-title":"PPARs at the crossroads of lipid signaling and inflammation","volume":"23","author":"Wahli","year":"2012","journal-title":"Trends Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.gene.2019.143947_bb0170","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1253\/circj.CJ-11-0060","article-title":"Role of peroxisome proliferator-activated receptor-\u03b3 in atherosclerosis: an update","volume":"75","author":"Wang","year":"2011","journal-title":"Circ. J."},{"issue":"3","key":"10.1016\/j.gene.2019.143947_bb0175","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.4238\/2012.May.18.13","article-title":"Association between PPAR\u03b32 Pro12Ala polymorphism and myocardial infarction and obesity in Han Chinese in Hohhot, China","volume":"11","author":"Wang","year":"2012","journal-title":"Genet. Mol. Res."},{"issue":"9","key":"10.1016\/j.gene.2019.143947_bb0180","doi-asserted-by":"crossref","first-page":"912","DOI":"10.5551\/jat.26138","article-title":"Association between peroxisome proliferator-activated receptor gamma gene polymorphisms and atherosclerotic diseases: a meta-analysis of case-control studies","volume":"22","author":"Wang","year":"2015","journal-title":"J. Atheroscler. Thromb."},{"issue":"1","key":"10.1016\/j.gene.2019.143947_bb0185","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.cmet.2011.05.009","article-title":"Adiponectin is required for PPAR\u03b3-mediated improvement of endothelial function in diabetic mice","volume":"14","author":"Wong","year":"2011","journal-title":"Cell Metab."},{"issue":"12","key":"10.1016\/j.gene.2019.143947_bb0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0053105","article-title":"The Pro12Ala polymorphism in the peroxisome proliferator-activated receptor gamma-2 gene (PPAR\u03b32) is associated with increased risk of coronary artery disease: a meta-analysis","volume":"7","author":"Wu","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.gene.2019.143947_bb0195","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s11033-012-2128-4","article-title":"The effect of PPARG gene polymorphisms on the risk of coronary heart disease: a meta-analysis","volume":"40","author":"Xu","year":"2013","journal-title":"Mol. Biol. Rep."},{"issue":"2","key":"10.1016\/j.gene.2019.143947_bb0200","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1006\/bbrc.1997.7798","article-title":"Molecular scanning of the human peroxisome proliferator activated receptor gamma (hPPAR gamma) gene in diabetic Caucasians: identification of a Pro12Ala PPAR gamma 2 missense mutation","volume":"241","author":"Yen","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1\u20132","key":"10.1016\/j.gene.2019.143947_bb0205","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s11010-011-0987-y","article-title":"Effects of the PPARG P12A and C161T gene variants on serum lipids in coronary heart disease patients with and without Type 2 diabetes","volume":"358","author":"Yilmaz-Aydogan","year":"2011","journal-title":"Mol. Cell. Biochem."},{"issue":"2","key":"10.1016\/j.gene.2019.143947_bb0210","first-page":"427","article-title":"Peroxisome proliferator-activated receptor gamma-2 P12A polymorphism and risk of acute myocardial infarction, coronary heart disease and ischemic stroke: a case-cohort study and meta-analyses","volume":"4","author":"Zafarmand","year":"2008","journal-title":"Vasc. Health Risk Manag."}],"container-title":["Gene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111919305979?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111919305979?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T16:25:19Z","timestamp":1759854319000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378111919305979"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":42,"alternative-id":["S0378111919305979"],"URL":"https:\/\/doi.org\/10.1016\/j.gene.2019.143947","relation":{},"ISSN":["0378-1119"],"issn-type":[{"type":"print","value":"0378-1119"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PPARA, PPARD and PPARG gene polymorphisms in patients with unstable angina","name":"articletitle","label":"Article Title"},{"value":"Gene","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gene.2019.143947","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"143947"}}